Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study
Allergology International · 2025-04 · 74 (2) · 292-300
DOI: 10.1016/j.alit.2024.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergology International, 2025-04. Verfasst von Akinari Sawada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Electronic address: a.sawada@omu.ac.jp. Hauptthemen laut MEDLINE: Eosinophilia, Gastritis, Enteritis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bristol-Myers Squibb, Bristol-Myers Squibb Co.
Abstract (Originalsprache)
BACKGROUND: Non-esophageal eosinophilic gastrointestinal diseases (non-EoE EGIDs) are allergic conditions where Th-2-predominant inflammation causes symptoms related to gastrointestinal tract dysfunction. No studies have reported the incidence of non-EoE EGIDs. In addition, little is known about the influence of lifestyle factors on the condition. METHODS: We used a large health claim database from January 2005 to September 2022. Non-EoE EGIDs cases were identified on the basis of the International Classification of Diseases-tenth Revision code, K52.8. The incidence and prevalence of non-EoE EGIDs were estimated by Poisson and binomial distribution, respectively. For each case, 10 controls were randomly selected for a nested case-control study to identify potential risk factors of non-EoE EGIDs. RESULTS: Of 15,200,895 individuals, 1,368 new cases of non-EoE EGIDs were identified. The incidence and prevalence of non-EoE EGIDs in 2022 were 3.07 (95% CI 2.67-3.52) per 100,000 person-years and 17.23 (95% CI 16.38-18.11) per 100,000 individuals, respectively, which were approximately 6 and 9 times higher than those in 2010. Allergic rhinitis (OR 1.63 (95% CI 1.16-2.29), p = 0.005), chronic sinusitis (OR 2.41 (95% CI 1.58-3.66), p < 0.001), and urticaria (OR 2.32 (95% CI 1.45-3.70), p < 0.001) were related to an increased risk of adult non-EoE EGIDs. Whilst atopic dermatitis (OR 2.28 (95% CI 1.35-3.86), p = 0.006) and the perinatal factors (OR 3.68 (95% CI 1.13-12.02), p = 0.031) were associated with an increased risk of pediatric non-EoE EGIDs. No association was seen with lifestyle factors such as obesity, smoking and alcohol consumption. CONCLUSIONS: The incidence and prevalence of non-EoE EGIDs have increased over the past two decades.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Electronic address: a.sawada@omu.ac.jp.
- Clinical and Translational Research Center, Kobe University Hospital, Hyogo, Japan.
- Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Förderung
- Bristol-Myers Squibb
- Bristol-Myers Squibb Co
Zitieren
APA
Sawada, A., Imai, T., Ihara, Y., Tanaka, F., & Fujiwara, Y. (2025). Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study. Allergology International, 74(2), 292-300. https://doi.org/10.1016/j.alit.2024.10.007
Vancouver
Sawada A, Imai T, Ihara Y, Tanaka F, Fujiwara Y. Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study. Allergology International. 2025;74(2):292-300. doi:10.1016/j.alit.2024.10.007
BibTeX
@article{Sawada2025,
author = {Sawada, Akinari and Imai, Takumi and Ihara, Yasutaka and Tanaka, Fumio and Fujiwara, Yasuhiro},
title = {Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study},
journal = {Allergology International},
year = {2025},
volume = {74},
number = {2},
pages = {292--300},
doi = {10.1016/j.alit.2024.10.007}
}
EUVIMED